Skip to main content

Graham Capital Management, L.P.

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1315421 ROWAYTON, CT

Position in RIGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$471,396
+$95,730 QoQ
Shares Held
12,050
-13.3% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#86
of 155 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. RIGL ranks #12 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $471,396 12,050
2026-03-31 $375,666 13,893
2025-12-31 $898,016 20,967
2025-09-30 $665,330 23,485
2025-06-30 $313,802 16,754
2025-03-31 $272,674 15,157
2024-12-31 $169,646 10,086
2024-03-31 $54,197 36,620
2023-12-31 $56,971 39,291
2023-09-30 $32,483 30,077
2023-06-30 $105,399 81,705
2023-03-31 $14,926 11,308
2022-09-30 $1,103,646 935,294
2022-06-30 $137,466 121,652
2022-03-31 $851,725 284,858
2021-12-31 $221,248 83,490